Laure Sarda-Mantel, Jidar Kaoutar, Toni Alfaiate, Amanda Lopes, Frédéric Paycha, Khadija Benali, Nidaa Mikail, Michael Soussan, Charles Lemarignier, Frédéric Méchaï, Sophie Le Nagat, Françoise Montravers, Ouda Deradji, Emmanuel Durand, Tiphaine Goulenok, Diane Ponscarme, Patrick Yéni, Cédric Laouénan, Christophe Rioux
Objective: In extra-pulmonary tuberculosis, therapeutic management is difficult in the absence of reliable tool to affirm healing at the end of treatment. In this prospective multicenter study, we evaluated [18 F]FDG-PET for this purpose. Methods: Forty-two patients out of 55 included patients could be analyzed. Additionally to usual biological, histological and morphological explorations, [18 F]FDG-PET was performed at diagnosis (PET1), at the end of treatment (PET2), indeed 6 months later. Then patients were followed until 12 months after end of prescribed treatment...
2021: Frontiers in Medicine